Evan Lippman
EVP, Business Development · 3 filings · Latest: Aug 17, 2026
TEVA PHARMACEUTICAL INDUSTRIES LTD
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TEVA | Evan Lippman | EVP, Business Development | Aug 17, 2026 | Sale | $36.57 | 18,600 | $680.3K | 25,591 | |
TEVA | Lippman Evan | — | Aug 17, 2026 | Proposed Sale | $36.57 | 18,600 | $680.3K | — | |
TEVA | Evan Lippman | EVP, Business Development | May 14, 2026 | Sale | $35.58 | 41,658 | $1.5M | 44,191 | |
TEVA | Evan Lippman | EVP, Business Development | May 14, 2026 | Option Exercise | — | 85,849 | — | 80,103 | |
TEVA | Lippman Evan | — | May 14, 2026 | Proposed Sale | $35.58 | 41,658 | $1.5M | — |